Kolkata, India: A 39-year-old British woman died in a Cypriot hospital following a blood clotting episode after getting the AstraZeneca Covid-19 vaccine, according to the official Cyprus News Agency.
The European Medicines Agency (EMA) will investigate the fatality, according to Charalambos Charilaou, a spokesperson for the state health services.
The woman was treated at Nicosia General Hospital’s intensive care unit and had her first dosage of the vaccination on May 6 in Paphos, a vacation town on the Mediterranean island’s western coast.
Also read | Bumps in the road for AstraZeneca vaccine
Days later, the woman, who has not been identified, began to have symptoms.
The Cyprus Ministry of Health has launched an investigation to establish if the “severe thrombotic event” was caused by the AstraZeneca vaccine.
Another case is being investigated by Cypriot authorities.
Cyprus is also looking into four other cases of “mild” blood clotting, three of which occurred after an AstraZeneca shot and one after a Pfizer vaccine.
Due to very uncommon blood clots, some nations have restricted or removed AstraZeneca vaccines from national immunization campaigns, despite the EMA’s assertion that the benefits outweigh the risks.
Also read | Questions about AstraZeneca jab linger
AstraZeneca is the driving force behind the immunization campaign in Cyprus, where family doctors are permitted to deliver the vaccine to anybody over the age of 20.
However, many customers who booked the vaccine online bypassed AstraZeneca in favor of other vaccines.
According to estimates from Our World in Data, Cyprus ranks third in the European Union for vaccinations per capita, with 57.54 doses administered per 100 persons.
Nearly 49% of Cyprus’ adult population has had a Covid-19 vaccination shot, with 21% of those who have gotten all vaccines.
Since the pandemic began in March 2020, there have been 71,911 infections and 354 deaths.